These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24066645)

  • 21. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The alterations of body composition in children with growth hormone deficiency during first two years of growth hormone treatment].
    Kucharska AM; Majcher A; Pyrzak B
    Pediatr Endocrinol Diabetes Metab; 2008; 14(3):145-9. PubMed ID: 18922218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders.
    Rogol AD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carotid intima-media thickness in children treated with growth hormone.
    Knop C; Wolters B; Lass N; Wunsch R; Reinehr T
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):985-91. PubMed ID: 25210755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
    Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
    Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone.
    Saygılı S; Kocaağa M; Kaya G; Şükür M; Baş F; Poyrazoğlu Ş; Bundak R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):69-80. PubMed ID: 36416456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of discontinuing growth hormone treatment.
    Cowan FJ; Evans WD; Gregory JW
    Arch Dis Child; 1999 Jun; 80(6):517-23. PubMed ID: 10331999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
    Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone.
    Bell W; Davies JS; Evans WD; Scanlon MF; Mullen R
    Am J Hum Biol; 2004; 16(5):533-43. PubMed ID: 15368601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular Function and Intima-Media Thickness in Children and Adolescents with Growth Hormone Deficiency: Results from a Prospective Case-Control Study.
    Improda N; Moracas C; Mattace Raso G; Valente V; Crisci G; Lorello P; Di Mase R; Salerno M; Capalbo D
    Horm Res Paediatr; 2024; 97(2):140-147. PubMed ID: 37290420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.